110 related articles for article (PubMed ID: 17891579)
1. Drug solubility in phospholipid carrier as a predictive parameter for drug recovery in microparticles produced by the aerosol solvent extraction system (ASES) process.
Sarisuta N; Kunastitchai S; Pichert L; Müller BW
Drug Dev Ind Pharm; 2007 Sep; 33(9):932-44. PubMed ID: 17891579
[TBL] [Abstract][Full Text] [Related]
2. Application of aerosol solvent extraction system (ASES) process for preparation of liposomes in a dry and reconstitutable form.
Kunastitchai S; Pichert L; Sarisuta N; Müller BW
Int J Pharm; 2006 Jun; 316(1-2):93-101. PubMed ID: 16621359
[TBL] [Abstract][Full Text] [Related]
3. Residual solvents in biodegradable microparticles. Influence of process parameters on the residual solvent in microparticles produced by the aerosol solvent extraction system (ASES) process.
Ruchatz F; Kleinebudde P; Muller BW
J Pharm Sci; 1997 Jan; 86(1):101-5. PubMed ID: 9002467
[TBL] [Abstract][Full Text] [Related]
4. Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process.
Bleich J; Müller BW
J Microencapsul; 1996; 13(2):131-9. PubMed ID: 8999119
[TBL] [Abstract][Full Text] [Related]
5. Physical and chemical stability of miconazole liposomes prepared by supercritical aerosol solvent extraction system (ASES) process.
Kunastitchai S; Sarisuta N; Panyarachun B; Müller BW
Pharm Dev Technol; 2007; 12(4):361-70. PubMed ID: 17763141
[TBL] [Abstract][Full Text] [Related]
6. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
7. Critical properties of lactide-co-glycolide polymers for the use in microparticle preparation by the aerosol solvent extraction system.
Engwicht A; Girreser U; Müller BW
Int J Pharm; 1999 Aug; 185(1):61-72. PubMed ID: 10425366
[TBL] [Abstract][Full Text] [Related]
8. Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles.
Scalia S; Mezzena M
Drug Dev Ind Pharm; 2009 Feb; 35(2):192-8. PubMed ID: 18785040
[TBL] [Abstract][Full Text] [Related]
9. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
[TBL] [Abstract][Full Text] [Related]
10. Development of β-cyclodextrin-based hydrogel microparticles for solubility enhancement of rosuvastatin: an in vitro and in vivo evaluation.
Sarfraz RM; Ahmad M; Mahmood A; Akram MR; Abrar A
Drug Des Devel Ther; 2017; 11():3083-3096. PubMed ID: 29123380
[TBL] [Abstract][Full Text] [Related]
11. Development and physicochemical evaluation of pharmacosomes of diclofenac.
Semalty A; Semalty M; Singh D; Rawat MS
Acta Pharm; 2009 Sep; 59(3):335-44. PubMed ID: 19819829
[TBL] [Abstract][Full Text] [Related]
12. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
[TBL] [Abstract][Full Text] [Related]
13. Microparticle size control and glimepiride microencapsulation using spray congealing technology.
Ilić I; Dreu R; Burjak M; Homar M; Kerc J; Srcic S
Int J Pharm; 2009 Nov; 381(2):176-83. PubMed ID: 19446625
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid microparticles produced by spray congealing: influence of the atomizer on microparticle characteristics and mathematical modeling of the drug release.
Passerini N; Qi S; Albertini B; Grassi M; Rodriguez L; Craig DQ
J Pharm Sci; 2010 Feb; 99(2):916-31. PubMed ID: 19569208
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
16. Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability.
Miriyala N; Ouyang D; Perrie Y; Lowry D; Kirby DJ
Eur J Pharm Biopharm; 2017 Jun; 115():197-205. PubMed ID: 28284728
[TBL] [Abstract][Full Text] [Related]
17. Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs.
Kuntsche J; Westesen K; Drechsler M; Koch MH; Bunjes H
Pharm Res; 2004 Oct; 21(10):1834-43. PubMed ID: 15553230
[TBL] [Abstract][Full Text] [Related]
18. Microparticles of soy lecithin formed by supercritical processes.
Badens E; Magnan C; Charbit G
Biotechnol Bioeng; 2001 Jan; 72(2):194-204. PubMed ID: 11114657
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability.
Lee S; Nam K; Kim MS; Jun SW; Park JS; Woo JS; Hwang SJ
Arch Pharm Res; 2005 Jul; 28(7):866-74. PubMed ID: 16114503
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy.
Scalia S; Salama R; Young P; Traini D
J Microencapsul; 2012; 29(3):225-33. PubMed ID: 22208706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
